drugset / Trial / NCT00346190
The Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture.
Phase 3
Unknown
10 enrolled
McGill University Health Centre/Research Institute of the McGill University Health Centre
Merck Frosst Canada Ltd. · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
To determine whether administration of Alendronate early is more effective than late in the prevention of osteoporosis following a hip fracture
Timeline
- Start
- 2003-01
- Primary completion
- —
- Completion
- 2007-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alendronic Acid | Small molecule | — | — |